Literature DB >> 19619707

Optical coherence tomography patterns of stent restenosis.

Nieves Gonzalo1, Patrick W Serruys, Takayuki Okamura, Heleen M van Beusekom, Hector M Garcia-Garcia, Gijs van Soest, Wim van der Giessen, Evelyn Regar.   

Abstract

BACKGROUND: Stent restenosis is an infrequent but poorly understood clinical problem in the drug-eluting stent era. The aim of the study was to evaluate the morphologic characteristics of stent restenosis by optical coherence tomography (OCT).
METHODS: Patients (n = 24, 25 vessels) presenting with angiographically documented stent restenosis were included. Quantitative OCT analysis consisted of lumen and stent area measurement and calculation of restenotic tissue area and burden. Qualitative restenotic tissue analysis included assessment of tissue structure, backscattering and symmetry, visible microvessels, lumen shape, and presence of intraluminal material.
RESULTS: By angiography, restenosis was classified as diffuse, focal, and at the margins in 9, 11, and 5 vessels, respectively. By OCT, restenotic tissue structure was layered in 52%, homogeneous in 28%, and heterogeneous in 20%. The predominant backscatter was high in 72%. Microvessels were visible in 12%. Lumen shape was irregular in 28% and there was intraluminal material in 20%. The mean restenotic tissue symmetry ratio was 0.58 +/- 0.19. Heterogeneous and low scattering restenotic tissue was more frequent in focal (45.5% and 54.5%, respectively) than in diffuse (0 and 11.1%) and margin restenosis (0 and 0%) (P = .005 for heterogeneous, P = .03 for low scattering). Restenosis patients with unstable angina symptoms presented more frequently irregular lumen shape (60 vs 6.7%, P = .007). Stents implanted </=12 months ago had more frequently restenotic tissue with layered appearance (84.6% vs 16.7%, P = .003).
CONCLUSIONS: We demonstrate the ability of OCT to identify differential patterns of restenotic tissue after stenting. This information could help in understanding the mechanism of stent restenosis.

Entities:  

Mesh:

Year:  2009        PMID: 19619707     DOI: 10.1016/j.ahj.2009.06.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  66 in total

1.  Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.

Authors:  Jingbo Hou; Haibo Jia; Haixia Liu; Zhigang Han; Shuang Yang; Chenyang Xu; Joseph Schmitt; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-16       Impact factor: 2.357

2.  Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.

Authors:  Qiang Fu; Hongyu Hu; Wei Chen; Zhixu Tan; Li Li; Dezhao Wang; Buxing Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Natural history of low-intensity neointimal tissue after an everolimus-eluting stent implantation: a serial observation with optical coherence tomography.

Authors:  Masahiko Shibuya; Kenichi Fujii; Masashi Fukunaga; Takahiro Imanaka; Kojiro Miki; Hiroto Tamaru; Mitsumasa Ohyanagi; Tohru Masuyama
Journal:  Heart Vessels       Date:  2013-12-29       Impact factor: 2.037

4.  Relationship between neointimal strut bridge and jailed side-branch ostial area.

Authors:  Xiangqi Wu; Wei You; Zhiming Wu; Fei Ye; Shaoliang Chen
Journal:  Herz       Date:  2019-09-25       Impact factor: 1.443

5.  Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns of in-stent restenosis among bare metal stents and drug eluting stents.

Authors:  Muzina Akhtar; Wei Liu
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

6.  Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.

Authors:  Sung-Joo Lee; Byeong-Keuk Kim; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Clin Cardiol       Date:  2011-09-16       Impact factor: 2.882

7.  Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.

Authors:  Takehiro Hashikata; Taiki Tojo; Sayaka Namba; Lisa Kitasato; Takuya Hashimoto; Ryo Kameda; Takao Shimohama; Minako Yamaoka-Tojo; Junya Ako
Journal:  Heart Vessels       Date:  2014-11-02       Impact factor: 2.037

8.  Late in-stent restenosis after sirolimus-eluting stent implantation is related to thrombus formation-Insight from a case with IVUS, OCT, and histological findings.

Authors:  Shigenori Ito; Kosuke Nakasuka; Kazuyuki Miyata; Masahiko Inomata; Takayuki Yoshida; Nozomu Tamai; Shin Suzuki; Yoshimasa Murakami; Shugo Suzuki; Koichi Sato
Journal:  J Cardiol Cases       Date:  2012-03-17

9.  Optical coherence tomography images of bell-shaped appearance in late sirolimus-eluting stent restenosis with extension of previous incomplete stent apposition.

Authors:  Tomokazu Iguchi; Takao Hasegawa; Satoshi Nishimura; Shinji Nakata; Toru Kataoka; Shoichi Ehara; Kenei Shimada; Akihisa Hanatani; Takashi Muro; Minoru Yoshiyama
Journal:  J Cardiol Cases       Date:  2011-08-27

10.  Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis.

Authors:  Seung-Yul Lee; Myeong-Ki Hong; Gary S Mintz; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang
Journal:  Int J Cardiovasc Imaging       Date:  2014-05-08       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.